Pathology News

Scientists at Yale’s Molecular Diagnostics Lab, part of the Department of Pathology, rose to the challenge of the COVID-19 pandemic. In March 2020, the pathologists had none of the equipment or space necessary and far too few technicians qualified to process COVID-19 tests. By December 2020, they had the capacity to run an estimated 1,200 tests a day. Over the course of the pandemic, the Molecular Diagnostics Lab evolved from manually processing nasopharyngeal swabs to playing a crucial role in the validation and execution of Yale’s own FDA-approved SalivaDirect test.

In honor of the 50th Anniversary of the National Cancer Act, Dr. Anna Arnal Estapé shares her motivation for pursuing a career in cancer research.

Scientists based at Yale University have been using multiplexed error robust fluorescence in situ hybridization (MERFISH) to investigate the spatial transcriptome profiles of individual cells in intact tissue.

In honor of the 50th Anniversary of the National Cancer Act, Dr. Natalia Buza shares her motivation for pursing a career in cancer research as a pathologist.

In honor of the 50th Anniversary of the National Cancer Act, Dr. Manoj Pillai shares his motivation for pursuing a career in cancer research.

New research at Yale has revealed major differences in aggressive types of breast cancer, and the potential for smarter treatments for patients. Triple-negative breast cancer, which has a low survival rate and a lack of helpful molecular biomarkers — specific proteins that signal the presence of disease — is among the most aggressive breast cancer subtypes.

While other, smaller studies have uncovered invaluable data about important aspects of the virus and the pandemic, this research and the resources that have gone into it promise to produce the most enlightening insights yet.

This award financially supports early career physician scientists to assist them in transitioning to independent research careers.

Lakshmanan Krishnamurti, MD, has been named Chief of Pediatric Hematology, Oncology, and Bone Marrow Transplant at Yale New Haven Children’s Hospital and Leader of the Smilow Cancer Hospital Pediatric Hematology/Oncology Program.